Advanced technology can help the pharmaceutical industry work through the inherent challenges of orphan drug development.
Innovative applications for AI are making news in the pharma industry. Here's an update on the latest.
Medical affairs organizations are seeking effective applications for advanced technologies.
New AI-driven Moderator Assistant changes how pharmaceutical companies approach insight gathering, engagement, and critical decision-making processes.
How data quality can impact life science AI adoption.
What does pharma need to make better decisions amid vast amounts of data?
65% say lack of insights endanger product launches, and 91% of medical affairs teams fail to use most of the data they collect to generate insights.
CEO Lance Hill talks about his key challenges, his day-to-day, and how he measures success.
Learn how oncology teams can use asynchronous engagement to support in-person activities and improve their insights management strategy.
Within3 experts share insight on how medical affairs teams can benefit from the data they collect.
